A citation-based method for searching scientific literature

Marianne Jetske Rutten, Roelien van de Vrie, Annemarie Bruining, Anje M Spijkerboer, Ben Willem Mol, Gemma Georgette Kenter, Marrije Renate Buist. Int J Gynecol Cancer 2015
Times Cited: 49







List of co-cited articles
410 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
Ignace Vergote, Claes G Tropé, Frédéric Amant, Gunnar B Kristensen, Tom Ehlen, Nick Johnson, René H M Verheijen, Maria E L van der Burg, Angel J Lacave, Pierluigi Benedetti Panici,[...]. N Engl J Med 2010
59

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.
Sean Kehoe, Jane Hook, Matthew Nankivell, Gordon C Jayson, Henry Kitchener, Tito Lopes, David Luesley, Timothy Perren, Selina Bannoo, Monica Mascarenhas,[...]. Lancet 2015
635
44

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.
Robert E Bristow, Rafael S Tomacruz, Deborah K Armstrong, Edward L Trimble, F J Montz. J Clin Oncol 2002
36

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.
Rudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, Jerrold B Teitcher, Svetlana Mironov, Revathy B Iyer, Qin Zhou, Alexia Iasonos, Harold Paul, Masayoshi Hosaka,[...]. Gynecol Oncol 2014
124
34


Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial.
Marianne J Rutten, Hannah S van Meurs, Roelien van de Vrie, Katja N Gaarenstroom, Christiana A Naaktgeboren, Toon van Gorp, Henk G Ter Brugge, Ward Hofhuis, Henk W R Schreuder, Henriette J G Arts,[...]. J Clin Oncol 2017
65
32

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.
R E Bristow, L R Duska, N C Lambrou, E K Fishman, M J O'Neill, E L Trimble, F J Montz. Cancer 2000
208
30

Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer.
Allison E Axtell, Margaret H Lee, Robert E Bristow, Sean C Dowdy, William A Cliby, Steven Raman, John P Weaver, Mojan Gabbay, Michael Ngo, Scott Lentz,[...]. J Clin Oncol 2007
165
30

A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study.
Anna Fagotti, Gabriella Ferrandina, Francesco Fanfani, Alfredo Ercoli, Domenica Lorusso, Marco Rossi, Giovanni Scambia. Ann Surg Oncol 2006
184
28

The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma.
Sean C Dowdy, Sally A Mullany, Kathy R Brandt, Bonnie J Huppert, William A Cliby. Cancer 2004
130
24

Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma.
Anna Fagotti, Gabriella Ferrandina, Francesco Fanfani, Giorgia Garganese, Giuseppe Vizzielli, Vito Carone, Maria Giovanna Salerno, Giovanni Scambia. Am J Obstet Gynecol 2008
161
22

Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma.
Mercedes Espada, Jose R Garcia-Flores, Mar Jimenez, Elena Alvarez-Moreno, Mar De Haro, Lucia Gonzalez-Cortijo, Gines Hernandez-Cortes, Vicente Martinez-Vega, Ricardo Sainz De La Cuesta. Eur Radiol 2013
51
22

Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept.
M Petrillo, G Vizzielli, F Fanfani, V Gallotta, F Cosentino, V Chiantera, F Legge, V Carbone, G Scambia, A Fagotti. Gynecol Oncol 2015
72
20

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
Alexi A Wright, Kari Bohlke, Deborah K Armstrong, Michael A Bookman, William A Cliby, Robert L Coleman, Don S Dizon, Joseph J Kash, Larissa A Meyer, Kathleen N Moore,[...]. J Clin Oncol 2016
211
20

A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer.
Rudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, Jerrold B Teitcher, Revathy B Iyer, Qin Zhou, Alexia Iasonos, John Denesopolis, Oliver Zivanovic, Kara C Long Roche,[...]. Gynecol Oncol 2017
51
20

Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer.
Marianne J Rutten, Mariska M G Leeflang, Gemma G Kenter, Ben Willem J Mol, Marrije Buist. Cochrane Database Syst Rev 2014
42
21


Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer.
Jo Marie Tran Janco, Gretchen Glaser, Bohyun Kim, Michaela E McGree, Amy L Weaver, William A Cliby, Sean C Dowdy, Jamie N Bakkum-Gamez. Gynecol Oncol 2015
27
29

Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer.
Katrijn Michielsen, Raphaëla Dresen, Ragna Vanslembrouck, Frederik De Keyzer, Frédéric Amant, Elvier Mussen, Karin Leunen, Patrick Berteloot, Philippe Moerman, Ignace Vergote,[...]. Eur J Cancer 2017
64
16

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
Dennis S Chi, Eric L Eisenhauer, Oliver Zivanovic, Yukio Sonoda, Nadeem R Abu-Rustum, Douglas A Levine, Matthew W Guile, Robert E Bristow, Carol Aghajanian, Richard R Barakat. Gynecol Oncol 2009
376
14


Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings.
Ha-Jeong Kim, Chel Hun Choi, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim. Taiwan J Obstet Gynecol 2014
15
46

A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer.
Anna Fagotti, Giuseppe Vizzielli, Pierandrea De Iaco, Daniela Surico, Alessandro Buda, Vincenzo Dario Mandato, Francesco Petruzzelli, Fabio Ghezzi, Salvatore Garzarelli, Liliana Mereu,[...]. Am J Obstet Gynecol 2013
75
14

Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients.
Seung-Hyuk Shim, Sun Joo Lee, Seon-Ok Kim, Soo-Nyung Kim, Dae-Yeon Kim, Jong Jin Lee, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam. Gynecol Oncol 2015
29
24

Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment.
Giovanni D Aletti, Eric L Eisenhauer, Antonio Santillan, Allison Axtell, Giacomo Aletti, Christine Holschneider, Dennis S Chi, Robert E Bristow, William A Cliby. Gynecol Oncol 2011
151
14

Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
14

Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.
Katrijn Michielsen, Ignace Vergote, Katya Op de Beeck, Frederic Amant, Karin Leunen, Philippe Moerman, Christophe Deroose, Geert Souverijns, Steven Dymarkowski, Frederik De Keyzer,[...]. Eur Radiol 2014
133
14

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.
Deborah K Armstrong, Brian Bundy, Lari Wenzel, Helen Q Huang, Rebecca Baergen, Shashikant Lele, Larry J Copeland, Joan L Walker, Robert A Burger. N Engl J Med 2006
12

Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon.
Giovanni D Aletti, Bobbie S Gostout, Karl C Podratz, William A Cliby. Gynecol Oncol 2006
114
12

A multicenter validation of computerized tomography models as predictors of non- optimal primary cytoreduction of advanced epithelial ovarian cancer.
O Gemer, M Gdalevich, M Ravid, B Piura, A Rabinovich, T Gasper, A Khashper, M Voldarsky, L Linov, I Ben Shachar,[...]. Eur J Surg Oncol 2009
31
19

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
D S Chi, E L Eisenhauer, J Lang, J Huh, L Haddad, N R Abu-Rustum, Y Sonoda, D A Levine, M Hensley, R R Barakat. Gynecol Oncol 2006
419
12

Optimal primary surgical treatment for advanced epithelial ovarian cancer.
Ahmed Elattar, Andrew Bryant, Brett A Winter-Roach, Mohamed Hatem, Raj Naik. Cochrane Database Syst Rev 2011
216
12

Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial.
Hannah S van Meurs, Parvin Tajik, Michel H P Hof, Ignace Vergote, Gemma G Kenter, Ben Willem J Mol, Marrije R Buist, Patrick M Bossuyt. Eur J Cancer 2013
73
12

Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.
Anna Fagotti, Gabriella Ferrandina, Giuseppe Vizzielli, Francesco Fanfani, Valerio Gallotta, Vito Chiantera, Barbara Costantini, Pasquale Alessandro Margariti, Salvatore Gueli Alletti, Francesco Cosentino,[...]. Eur J Cancer 2016
203
12


A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model.
Giovanni D Aletti, Antonio Santillan, Eric L Eisenhauer, Jae Hu, Giacomo Aletti, Karl C Podratz, Robert E Bristow, Dennis S Chi, William A Cliby. Gynecol Oncol 2007
130
12

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
Alexi A Wright, Kari Bohlke, Deborah K Armstrong, Michael A Bookman, William A Cliby, Robert L Coleman, Don S Dizon, Joseph J Kash, Larissa A Meyer, Kathleen N Moore,[...]. Gynecol Oncol 2016
140
12

Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182.
Neil S Horowitz, Austin Miller, Bunja Rungruang, Scott D Richard, Noah Rodriguez, Michael A Bookman, Chad A Hamilton, Thomas C Krivak, G Larry Maxwell. J Clin Oncol 2015
142
10

Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery?
A Fagotti, F Fanfani, G Vizzielli, V Gallotta, A Ercoli, A Paglia, B Costantini, M Vigliotta, G Scambia, G Ferrandina. Gynecol Oncol 2010
43
11

Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO stage IIIc ovarian cancer patients.
Francesco Fanfani, Gabriella Ferrandina, Giacomo Corrado, Anna Fagotti, Haim Vito Zakut, Salvatore Mancuso, Giovanni Scambia. Oncology 2003
62
10

Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer.
J Borley, C Wilhelm-Benartzi, J Yazbek, R Williamson, N Bharwani, V Stewart, I Carson, E Hird, A McIndoe, A Farthing,[...]. BJOG 2015
21
23

Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial.
G Ferrandina, G Sallustio, A Fagotti, G Vizzielli, A Paglia, E Cucci, A Margariti, L Aquilani, G Garganese, G Scambia. Br J Cancer 2009
61
10


Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study.
Scott M Eisenkop, Nick M Spirtos, Richard L Friedman, Wei-Chien Michael Lin, Albert L Pisani, Sergio Perticucci. Gynecol Oncol 2003
267
10

A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer.
Johanna Hynninen, Jukka Kemppainen, Maija Lavonius, Johanna Virtanen, Jaakko Matomäki, Sinikka Oksa, Olli Carpén, Seija Grénman, Marko Seppänen, Annika Auranen. Gynecol Oncol 2013
57
10

Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
Mirjam J A Engelen, Henrike E Kos, Pax H B Willemse, Jan G Aalders, Elisabeth G E de Vries, Michael Schaapveld, Renee Otter, Ate G J van der Zee. Cancer 2006
195
10

Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis.
Jeroen Kaijser, Ahmad Sayasneh, Kirsten Van Hoorde, Sadaf Ghaem-Maghami, Tom Bourne, Dirk Timmerman, Ben Van Calster. Hum Reprod Update 2014
105
10



A framework for a personalized surgical approach to ovarian cancer.
Alpa M Nick, Robert L Coleman, Pedro T Ramirez, Anil K Sood. Nat Rev Clin Oncol 2015
89
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.